Polymer blends medical applications, copolymers

Fibres can be produced either by using a single polymer or by blending a copolymer of PLA and PGA. Varying the proportion of PLA and PGA alters the degradation rate and strength retention time of the fibre. These properties can, therefore, be varied in this way according to the requirements of specific medical applications. 

Substitute for Conventional Vulcanized Rubbers, For this application, the products are processed by techniques and equipment developed for conventional thermoplastics, ie, injection molding, extrusion, etc. The S—B—S and S—EB—S polymers are preferred (small amounts of S—EP—S are also used). To obtain a satisfactory balance of properties, they must be compounded with oils, fillers, or other polymers compounding reduces costs. Compounding ingredients and their effects on properties are given in Table 8. Oils with high aromatic content should be avoided because they plasticize the polystyrene domains. Polystyrene is often used as an ingredient in S—B—S-based compounds it makes the products harder and improves their processibility. In S—EB—S-based compounds, crystalline polyolefins such as polypropylene and polyethylene are preferred. Some work has been reported on blends of liquid polysiloxanes with S—EB—S block copolymers. The products are primarily intended for medical and pharmaceutical-type applications and hardnesses as low as 5 on the Shore A scale have been reported (53). 

---